The treatment of Parkinson’s disease often requires the use of multiple agents to achieve optimal symptom control with minimal side effects.
The mainstay of treatment is levodopa, however the development of movement disorders occurs with long term treatment. In younger patients, therefore, it may be preferable to reserve levodopa for use later in the course of disease progression. Also, in patients taking long term levodopa, additional therapies may help to reduce motor fluctuations.
Read the complete bulletin: